Redox-sensitive mechanisms of phytochemical-mediated inhibition of cancer cell proliferation

Journal of Nutritional Biochemistry

Volumn 14, Issue 2, 2003, Pages 64-73

  Loo, George ^a  

^a UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

Author keywords

Hydrogen peroxide; Isothiocyanates; Phenolic phytochemicals; Redox sensitive genes; Signal transduction

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; BENZYL ISOTHIOCYANATE; DNA; HYDROGEN PEROXIDE; ISOTHIOCYANIC ACID DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; PHENOL DERIVATIVE; PHENYLETHYLISOTHIOCYANATE; PHENYLMETHYLISOTHIOCYANATE; PHYTOCHEMICAL; REACTIVE OXYGEN METABOLITE; SCAVENGER; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CHEMOPROPHYLAXIS; DNA DAMAGE; DRUG MECHANISM; EARLY RESPONSE GENE; GENE ACTIVATION; HUMAN; METASTASIS POTENTIAL; MITOSIS INHIBITION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PLANT PRODUCT; SIGNAL TRANSDUCTION;

EID: 0037298781     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-2863(02)00251-6     Document Type: Review

References (80)

1. Shahidi F., Wanasundara P.K.J.P.D. Phenolic antioxidants. Crit Rev Food Sci Nutr. 32:1992;67-103.
2. Hecht S.S. Inhibition of carcinogenesis by isothiocyanates. Drug Metab Rev. 32:2000;395-411.
3. Talalay P., Fahey J.W. Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. J Nutr. 131:2001;3027S-3033S.
4. Stoner G.D., Mukhtar H. Polyphenols as cancer chemopreventive agents. J Cell Biochem Supplement. 22:1995;169-180.
5. Szatrowski T.P., Nathan C.F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 51:1991;794-798.
6. Benhar M., Dalyot I., Engelberg D., Levitzki A. Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol Cell Biol. 21:2001;6913-6926.
7. Toyokuni S., Okamoto K., Yodoi J., Hiai H. Persistent oxidative stress in cancer. FEBS Lett. 358:1995;1-3.
8. Kondo S., Toyokuni S., Iwasa Y., Tanaka T., Onodera H., Hiai H., Imamura M. Persistent oxidative stress in human colorectal carcinoma, but not in adenoma. Free Radic Biol Med. 27:1999;401-410.
9. Halliwell B., Gutteridge J.M.C. Role of free radicals and catalytic metal ions in human disease an overview . Methods Enzymol. 186:1990;1-85.
10. Mello-Filho A.C., Meneghini R. Iron is the intracellular metal involved in the production of DNA damage by oxygen radicals. Mutat Res. 251:1991;109-113.
11. Elledge R.M., Lee W.-H. Life and death by p53. BioEssays. 17:1995;923-930.
12. Khan A.U., Wilson T. Reactive oxygen species as cellular messengers. Chem Biol. 2:1995;437-445.
13. Parrett M.L., Harris R.E., Joarder F.S., Ross M.S., Clausen K.P., Robertson F.M. Cyclooxygenase-2 gene expression in human breast cancer. Int J Oncol. 10:1997;503-507.
14. Sano H., Kawahito Y., Wilder R.L., Hashiramoto A., Mukai S., Asai K., Kimura S., Kato H., Kondo M., Hla T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55:1995;3785-3789.
15. Kulkarni S., Rader J.S., Zhang F., Liapis H., Koki A.T., Masferrer J.L., Subbaramaiah K., Dannenberg A.J. Cyclooxygenase-2 is overexpressed in human cervical cancer. Clin Cancer Res. 7:2001;429-434.
16. 2 transactivates EGF receptor a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy . Nature Med. 8:2002;289-293.
17. Westermarck J., Kahari V.-M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13:1999;781-792.
18. Nozoe T., Korenaga D., Kabashima A., Ohga T., Saeki H., Sugimachi K. Significance of cyclin b1 expression as an independent prognostic indicator of patients with squamous cell carcinoma of the esophagus. Clin Cancer Res. 8:2002;817-822.
19. Meng T.C., Fukada T., Tonks N.K. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell. 9:2002;387-399.
20. Bae Y.S., Kang S.W., Seo M.S., Baines I.C., Tekle E., Chock P.B., Rhee S.G. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide role in EGF receptor-mediated tyrosine phosphorylation . J Biol Chem. 272:1997;217-221.
21. 2 . Eur J Biochem. 267:2000;1933-1944.
22. 2 mediates oxidative stress-induced epidermal growth factor receptor phosphorylation. Toxicol Lett. 122:2001;205-214.
23. Dabrowski A., Boguslowicz C., Dabrowska M., Tribillo I., Gabryelewicz A. Reactive oxygen species activate mitogen-activated protein kinases in pancreatic acinar cells. Pancreas. 21:2000;376-384.
24. Specht M.C., Barden C.B., Fahey T.J. p44/p42-MAP kinase expression in papillary thyroid carcinomas. Surgery. 130:2001;936-940.
25. Leirdal M., Sioud M. Tyrosine kinase receptor-ras-ERK signal transduction pathway as therapeutic target in cancer. Tidsskr Nor Laegeforen. 122:2002;178-182.
26. Meyer M., Pahl H.L., Baeuerle P.A. Regulation of the transcription factors NF-kappa B and AP-1 by redox changes. Chem Biol Interact. 91:1994;91-100.
27. Muller J.M., Rupec R.A., Baeuerle P.A. Study of gene regulation by NF-kappa B and AP-1 in response to reactive oxygen intermediates. Methods. 11:1997;301-312.
28. Hsu T.C., Young M.R., Cmarik J., Colburn N.H. Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis. Free Radic Biol Med. 28:2000;1338-1348.
29. Li J.J., Cao Y., Young M.R., Colburn N.H. Induced expression of dominant-negative c-jun downregulates NFkappaB and AP-1 target genes and suppresses tumor phenotype in human keratinocytes. Mol Carcinog. 29:2000;159-169.
30. Mukhopadhyay A., Bueso-Ramos C., Chatterjee D., Pantaziis P., Aggarwal B.B. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene. 20:2001;7597-7609.
31. Hardwick J.C., van G.R., Offerhaus G.J., van Deventer S.J., Peppelenbosch M.P. NF-kappaB, p38 MAPK and JNK are highly expressed and active in the stroma of human colonic adenomatous polyps. Oncogene. 20:2001;819-827.
32. Lim J.W., Kim H., Kim K.H. Nuclear factor-κB regulates cyclooxygenase-2 expression and cell proliferation in human gastric cancer cells. Lab Invest. 81:2001;349-360.
33. Guo Y.S., Hellmich M.R., Wen X.D., Townsend C.M. Jr. Activator protein-1 transcription factor mediates bombesin-stimulated cyclooxygenase-2 expression in intestinal epithelial cells. J Biol Chem. 276:2001;22941-22947.
34. Dhawan P., Richmond A. A novel NF-kappa B-inducing kinase-MAPK signaling pathway up-regulates NF-kappa B activity in melanoma cells. J Biol Chem. 277:2002;7920-7928.
35. Nakshatri H., Bhat-Nakshatri P., Martin D.A., Goulet R.J., Sledge G.W. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth. Mol Cell Biol. 17:1997.
36. Smirnov A.S., Ruzov A.S., Budanov A.V., Prokhortchouk A.V., Ivanov A.V., Prokhortchouk E.B. High constitutive level of NF-κB is crucial for viability of adenocarcinoma cells. Cell Death Different. 8:2001;621-630.
37. Simon C., Simon M., Vucelic G., Hicks M.J., Plinkert P.K., Koitschev A., Zenner H.P. The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation. Exp Cell Res. 271:2001;344-355.
38. Dang C.V., Resar L.M.S., Emison E., Kim S., Li Q., Prescott J.E., Wonsey D., Zeller K. Function of the c-myc oncogenic transcription factor. Exp Cell Res. 253:1999;63-77.
39. Geddert H., Heep H.J., Gabbert H.E., Sarbia M. Expression of cyclin B1 in the metaplasia-dysplasia-carcinoma sequence of Barrett esophagus. Cancer. 94:2002;212-218.
40. Menssen A., Hermeking H. Characterization of the c-MYC-regulated transcriptiome by SAGE identification and analysis of c-MYC target genes . Proc Natl Acad Sci USA. 99:2002;6274-6279.
41. Kurata S. Selective activation of p38 MAPK cascade and mitotic arrest caused by low level oxidative stress. J Biol Chem. 275:2000;23413-23416.
42. Kim D.K., Cho E.S., Seong J.K., Um H.-D. Adaptive concentrations of hydrogen peroxide suppress cell death by blocking the activation of SAPK/JNK pathway. Cell Science. 114:2001;4329-4334.
43. Salh B.S., Martens J., Hundal R.S., Yoganathan N., Charest D., Mui A., Gomez-Munoz A. PD98059 attentuates hydrogen peroxide-induced cell death through inhibition of Jun N-terminal kinase in HT29 cells. Mol Cell Biol Res Commun. 4:2000;158-165.
44. Katiyar S.K., Afaq F., Azizuddin K., Mukhtar H. Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate. Toxicol Applied Pharm. 176:2001;110-117.
45. Manna S.K., Mukhopadhyay A., Aggarwal B.B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κB, activator protein-1, and apoptosis potential role of reactive oxygen intermediates and lipid peroxidation . J Immunol. 164:2000;6509-6519.
46. Yu R., Hebbar V., Kim D.W., Mandlekar S., Pezzuto J.M., Kong A.N. Resveratrol inhibits phorbol ester and UV-induced activator protein 1 activation by interfering with mitogen-activated protein kinase pathways. Mol Pharmacol. 60:2001;217-224.
47. Yin F., Giuliano A.E., van Herle A.J. Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO). Anticancer Res. 19:1999;4297-4303.
48. 1 -phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res. 7:2001;1466-1473.
49. 2 -terminal kinases in resveratrol-induced activation of p53 and apoptosis. Mol Carcinog. 33:2002;244-250.
50. Mouria M., Gukovskaya A.S., Jung Y., Buechler P., Hines O.J., Reber H.A., Pandol S.J. Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis. Int J Cancer. 98:2002;761-769.
51. Long L.H., Clement M.V., Halliwell B. Artifacts in cell culture rapid generation of hydrogen peroxide on addition of (-)-epigallocatechin, (-)-epigallocatechin gallate, (+)-catechin, and quercetin to commonly used cell culture media . Biochem Biophys Res Commun. 273:2000;50-53.
52. Valerio L.G., Kepa J.K., Pickwell G.V., Quattrochi L.C. Induction of human NAD(P)H quinone oxidoreductase (NQO1) gene expression by the flavonol quercetin . Toxicol Lett. 119:2001;49-57.
53. 2 production in transformed and non-transformed human bronchial cell lines possible mechanisms of cell growth inhibition and apoptosis induction . Carcinogenesis. 21:2000;2035-2039.
54. Sakagami H., Arakawa H., Maeda M., Satoh K., Kadofuku T., Fukuchi K., Gomi K. Production of hydrogen peroxide and methionine sulfoxide by epigallocatechin gallate and antioxidants. Anticancer Res. 21:2001;2633-2641.
55. Park J.W., Choi Y.J., Suh S.I., Kwon T.K. Involvement of ERK and protein tyrosine phosphatase signaling pathways in EGCG-induced cyclooxygenase-2 expression in Raw 264.7 cells. Biochem Biophys Res Commun. 286:2001;721-725.
56. Galan A., Garcia-Bermejo M.L., Troyano A., Vilaboa N.E., deBlas E., Kazanietz M.G., Aller P. Stimulation of p38 mitogen-activated protein kinase is an early regulatory event for the cadmium-induced apoptosis in human promonocytic cells. J Biol Chem. 275:2000;11418-11424.
57. Chen C., Yu R., Owuor E.D., Kong A.N. Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch Pharm Res. 23:2000;605-612.
58. Shih A., Davis F.B., Lin H.Y., Davis P.J. Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism. J Clin Endocrinol Metab. 87:2002;1223-1232.
59. Johnson M.K., Loo G. Effects of epigallocatechin gallate and quercetin on oxidative DNA damage to cellular DNA. Mutation Res. 459:2000;211-218.
60. Kelly M.R., Xu J., Alexander K.E., Loo G. Disparate effects of similar phenolic phytochemicals as inhibitors of oxidative damage to cellular DNA. Mutation Res. 485:2001;309-318.
61. Lu J., Ho C.T., Ghai G., Chen K.Y. Differential effects of theaflavin monogallates on cell growth, apoptosis, and Cox-2 gene expression in cancerous versus normal cells. Cancer Res. 60:2000;6465-6471.
62. Sakagami H., Jiang Y., Kusama K., Atsumi T., Ueha T., Toguchi M., Iwakura I., Satoh K., Ito H., Hatano T., Yoshida T. Cytotoxic activity of hydrolyzable tannins against human oral tumor cell lines a possible mechanism . Phytomedicine. 7:2000;39-47.
63. Zhang Y., Talalay P. Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic phase 2 enzymes. Cancer Res. 58:1998;4632-4639.
64. Ye L., Zhang Y. Total intracellular accumulation levels of dietary isothiocyanates determine their activity in elevation of cellular glutathione and induction of phase 2 detoxification enzymes. Carcinogenesis. 22:2001;1987-1992.
65. Kolm R.H., Danielson U.H., Zhang Y., Talalay P., Mannervik B. Isothiocyanates as substrates for human glutathione transferases structure-activity studies . Biochem J. 311:1995;453-459.
66. Nakamura Y., Ohigashi H., Masuda S., Murakami A., Morimitsu Y., Kawamoto Y., Osawa T., Imagawa M., Uchida K. Redox regulation of glutathione S-transferase induction by benzyl isothiocyanate correlation of enzyme induction with the formation of reactive oxygen intermediates . Cancer Res. 60:2000;219-225.
67. Kassie F., Pool-Zobel B., Parzefall W., Knasmuller S. Genotoxic effects of benzyl isothiocyanate, a natural chemopreventive agent. Mutagenesis. 14:1999;595-603.
68. Gamet-Payrastre L., Li P., Lumeau S., Cassar G., Dupont M.-A., Chevolleau S., Gasc N., Tulliez J., Terce F. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res. 60:2000;1426-1433.
69. Fimognari C., Nusse M., Cesari R., Iori R., Cantelli-Forti G., Hrelia P. Growth inhibition, cell cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane. Carcinogenesis. 23:2002;581-586.
70. Huang C., Ma W., Li J., Hecht S.S., Dong Z. Essential role of p53 in phenethyl isothiocyanate-induced apoptosis. Cancer Res. 58:1998;4102-4106.
71. Yu R., Mandlekar S., Harvey K.J., Ucker D.S., Kong A.-N.T. Chemopreventive isothiocyanates induce apoptosis and caspase-3-like protease activity. Cancer Res. 58:1998;402-408.
72. Nakamura Y., Kawakami M., Yoshihiro A., Miyoshi N., Ohigashi H., Kawai K., Osawa T., Uchida K. Involvement of the mitochondrial death pathway in chemopreventive benzyl isothiocyanate-induced apoptosis. J Biol Chem. 277:2002;8492-8499.
73. Chen Y.-R., Wang W., Kong A.-N.T., Tan T.-H. Molecular mechanisms of c-Jun N-terminal kinase-mediated apoptosis induced by anticarcinogenic isothiocyanates. J Biol Chem. 273:1998.
74. Xu K., Thornalley P.J. Signal transduction activated by the cancer chemopreventive isothiocyanates cleavage of BID protein, tyrosine phosphorylation and activation of JNK . Br J Cancer. 84:2001;670-673.
75. Tong T., Fan W., Zhao H., Jin S., Fan F., Blanck P., Alomo I., Rajasekaran B., Liu Y., Holbrook N.J., Zhan Q. Involvement of the MAP kinase pathways in induction of GADD45 following UV radiation. Exp Cell Res. 269:2001;64-72.
76. Zhao H., Jin S., Fan F., Fan W., Tong T., Zhan Q. Activation of the transcription factor Oct-1 in response to DNA damage. Cancer Res. 60:2000;6276-6280.
77. Jin S., Fan F., Fan W., Zhao H., Tong T., Blanck P., Alomo I., Rajasekaran B., Zhan Q. Transcription factors Oct-1 and NF-YA regulate the p53-indpendent induction of the GADD45 following DNA damage. Oncogene. 20:2001;2683. 2390.
78. Guyton K.Z., Xu Q., Holbrook N.J. Induction of the mammalian stress response gene GADD153 by oxidative stress role of AP-1 element . Biochem J. 314:1996;547-554.
79. Kong A.N., Yu R., Chen C., Mandlekar S., Primiano T. Signal transduction events elicited by natural products role of MAPK and caspase pathways in homeostatic response and induction of apoptosis . Arch Pharm Res. 23:2000;1-16.
80. Kong A.-N.T., Yu R., Hebbar V., Chen C., Owuor E., Hu R., Ee R., Mandlekar S. Signal transduction events elicited by cancer prevention compounds. Mutation Res 480-. 481:2001;231-241.